Morten Salling Olesen receives a Hallas-Møller Emerging Investigator Grant
Associate professor Morten Salling Olesen has received one of the prestigious Hallas-Møller Emerging Investigator grants from the Novo Nordisk Foundation for the project “Nationwide study of the genetics behind atrial fibrillation”.
In October 2017, the Department’s leadership team encouraged researchers at BMI to apply for funding from the Novo Nordisk Foundation’s (NNF) new research leader programme. BMI submitted 5 applications within the three different types of grants in NNF’s research leader programme and among these, 3 of the applications were for the Hallas-Møller Emerging Investigator grants where Associate professor Morten Salling Olesen received one of the grants of DKK 10 million.
Associate professor Morten Salling Olesen has received the Hallas-Møller Emerging Investigator grant for his project “Nationwide study of the genetics behind atrial fibrillation”. Morten describes the project as: “Atrial fibrillation is the most common form of irregular heart rhythm. The disease is associated with a rapid heart rate and an increased risk of stroke. Little is known about the biological mechanisms underlying the disease. We have identified atrial fibrillation patients with substantial genetic predisposition. We will study these patients by DNA sequencing to identify the genes involved in disease development”.